Trinity Pharma nets $15 mln in Series A funds

Trinity Pharma has closed $15 million in Series A funding. New York growth equity firm Health Enterprise Partners led the round. Also, David Tamburri, general partner at HEP, will join Trinity's board of directors. Based in Waltham, Mass., Trinity Pharma is a provider of cloud-based data, analytics and mobile solutions for the global life sciences industry.

North AmericaUSBriefs